The dynamic of concentration of von Willebrand factor concentration in peracute and acute periods of cardioembolic stroke during heparin therapy
The concomitant use of heparin with antiplatelet agents, particularly with aspirin in CES, enhances its anticoagulant activity and inhibits platelets in the test with arachidonic acid. Continued high ristocetin- and collagen-induced platelet aggregation supports the use of vasoprotective agents activating metabolic processes in the walls of blood vessels to correct persistent endothelial dysfunction.
Authors
- Trần Minh Đức (ORCID: https://orcid.org/0000-0002-3146-0822)
- E A Koltsova (ORCID: https://orcid.org/0000-0001-6459-2656)
- G. G. Avakyan (ORCID: https://orcid.org/0000-0002-8985-8227)
- Elizaveta A. Petrova (ORCID: https://orcid.org/0000-0002-9679-7899)
- M. Kh. Shurdumova (ORCID: https://orcid.org/0000-0003-4639-7237)
- A. N. Yasamanova
Institutions
- Pirogov Russian National Research Medical University (RU)
- City Clinical Hospital No 31 (RU)
Publication Details
- Journal
- S S Korsakov Journal of Neurology and Psychiatry
- Published
- 2025-03-21
- DOI
- https://doi.org/10.17116/jnevro202512503269
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00